41417511000001101: Carbimazole 5mg tablets (Glenmark Pharmaceuticals Europe Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Carbimazole 5mg tablets (Glenmark Pharmaceuticals Europe Ltd)
\UK product\Virtual medicinal product\Product containing precisely carbimazole 5 milligram/1 each conventional release oral tablet\Carbimazole 5mg tablets (Glenmark Pharmaceuticals Europe Ltd)
\UK product\Virtual therapeutic moiety\Carbimazole\Product containing only carbimazole in oral dose form (medicinal product form)\Product containing precisely carbimazole 5 milligram/1 each conventional release oral tablet\Carbimazole 5mg tablets (Glenmark Pharmaceuticals Europe Ltd)
\UK product\Virtual therapeutic moiety\Carbimazole\Product containing precisely carbimazole 5 milligram/1 each conventional release oral tablet\Carbimazole 5mg tablets (Glenmark Pharmaceuticals Europe Ltd)

\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing thiourea\Product containing carbimazole\Carbimazole\Product containing only carbimazole in oral dose form (medicinal product form)\Product containing precisely carbimazole 5 milligram/1 each conventional release oral tablet\Carbimazole 5mg tablets (Glenmark Pharmaceuticals Europe Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing thiourea\Product containing carbimazole\Carbimazole\Product containing precisely carbimazole 5 milligram/1 each conventional release oral tablet\Carbimazole 5mg tablets (Glenmark Pharmaceuticals Europe Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing thiourea\Product containing carbimazole\Product containing carbimazole in oral dose form (medicinal product form)\Product containing only carbimazole in oral dose form (medicinal product form)\Product containing precisely carbimazole 5 milligram/1 each conventional release oral tablet\Carbimazole 5mg tablets (Glenmark Pharmaceuticals Europe Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing sulfur and/or sulfur compound (product)\Product containing thiourea\Product containing carbimazole\Carbimazole\Product containing only carbimazole in oral dose form (medicinal product form)\Product containing precisely carbimazole 5 milligram/1 each conventional release oral tablet\Carbimazole 5mg tablets (Glenmark Pharmaceuticals Europe Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing sulfur and/or sulfur compound (product)\Product containing thiourea\Product containing carbimazole\Carbimazole\Product containing precisely carbimazole 5 milligram/1 each conventional release oral tablet\Carbimazole 5mg tablets (Glenmark Pharmaceuticals Europe Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing sulfur and/or sulfur compound (product)\Product containing thiourea\Product containing carbimazole\Product containing carbimazole in oral dose form (medicinal product form)\Product containing only carbimazole in oral dose form (medicinal product form)\Product containing precisely carbimazole 5 milligram/1 each conventional release oral tablet\Carbimazole 5mg tablets (Glenmark Pharmaceuticals Europe Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antithyroid agent (product)\Product containing carbimazole\Carbimazole\Product containing only carbimazole in oral dose form (medicinal product form)\Product containing precisely carbimazole 5 milligram/1 each conventional release oral tablet\Carbimazole 5mg tablets (Glenmark Pharmaceuticals Europe Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antithyroid agent (product)\Product containing carbimazole\Carbimazole\Product containing precisely carbimazole 5 milligram/1 each conventional release oral tablet\Carbimazole 5mg tablets (Glenmark Pharmaceuticals Europe Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antithyroid agent (product)\Product containing carbimazole\Product containing carbimazole in oral dose form (medicinal product form)\Product containing only carbimazole in oral dose form (medicinal product form)\Product containing precisely carbimazole 5 milligram/1 each conventional release oral tablet\Carbimazole 5mg tablets (Glenmark Pharmaceuticals Europe Ltd)
\Medicinal product\Product manufactured as oral dose form\Product containing carbimazole in oral dose form (medicinal product form)\Product containing only carbimazole in oral dose form (medicinal product form)\Product containing precisely carbimazole 5 milligram/1 each conventional release oral tablet\Carbimazole 5mg tablets (Glenmark Pharmaceuticals Europe Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 15-Feb 2023. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

2604221000001118 Carbimazole 5mg tablets (Glenmark Pharmaceuticals Europe Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

2604241000001111 Carbimazole 5mg tablets (Glenmark Pharmaceuticals Europe Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Carbimazole 5mg tablets (Glenmark Pharmaceuticals Europe Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Carbimazole 5mg tablets (Glenmark Pharmaceuticals Europe Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none	true	Inferred relationship	Existential restriction modifier
Carbimazole 5mg tablets (Glenmark Pharmaceuticals Europe Ltd)	Is a	Product containing precisely carbimazole 5 milligram/1 each conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Carbimazole 5mg tablets (Glenmark Pharmaceuticals Europe Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Carbimazole 5mg tablets (Glenmark Pharmaceuticals Europe Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Carbimazole 5mg tablets (Glenmark Pharmaceuticals Europe Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Carbimazole 5mg tablets (Glenmark Pharmaceuticals Europe Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Carbimazole 5mg tablets (Glenmark Pharmaceuticals Europe Ltd)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Carbimazole 5mg tablets (Glenmark Pharmaceuticals Europe Ltd)	Has specific active ingredient	Carbimazole	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Carbimazole 5mg tablets (Glenmark Pharmaceuticals Europe Ltd) 100 tablet	Has AMP	True	Carbimazole 5mg tablets (Glenmark Pharmaceuticals Europe Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
2604221000001118	Carbimazole 5mg tablets (Glenmark Pharmaceuticals Europe Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
2604241000001111	Carbimazole 5mg tablets (Glenmark Pharmaceuticals Europe Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module